Q2 results

This page shows the latest Q2 results news and features for those working in and with pharma, biotech and healthcare.

Bristol-Myers Squibb’s revenues rise on Celgene acquisition

The positive quarterly results build on BMS’ key patent challenge victory on Wednesday for its blood thinner Eliquis (apixaban). ... One concerning caveat among the otherwise positive results was the decrease in sales for BMS’ immunotherapy Opdivo,

Latest news

Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops

Disruption to uptake of HIV and hepatitis C drugs caused by pandemic
AstraZeneca escapes pandemic impact as new drugs bolster revenues

That includes a rise in product sales, with a 6% increase in Q2 to $6.04bn and an 11% increase to $12.36bn for the half year. ... The pharma giant seems to have avoided any significant effects on its earnings in the quarter, compared to other drugmakers
Roche cites COVID-19 and biosimilars in Q2 decline

Pharmaceutical sales took a 4% hit in Swiss francs. Swiss pharma Roche is the latest pharma company to be hit in its second quarter results by the COVID-19 pandemic, with ... Roche’s diagnostic division results were a mixed bag, with overall sales
Biogen raises full year guidance after beating Q2 expectations

Prior to the results presentation, investors were rocked by the unexpected news that Biogen’s chief financial officer Jeffrey Capello was departing from the company. ... Biogen completed a marketing application for the high-risk Alzheimer’s therapy
Novartis stumbles in Q2 as COVID-19 impacts sales

The company reported that net income was down 11% to $1.9bn compared with last year’s second quarter results. ... Despite the somewhat marred results, there were some highlights in the Q2 results, including a strong launch for the company’s spinal

More from news
Approximately 13 fully matching, plus 25 partially matching documents found.

Latest Intelligence

Interview: Joseph Jimenez, Novartis

Our broad, yet focused, portfolio delivered strong results in Q2, with sales growing 19 per cent. ... Consumer health grew five per cent in Q2, largely due to products like Theraflu and Voltaren.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Healthcare Account Director: Competitive

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Medical Editor: Competitive

Account Director – Creative Healthcare Communications: Competative

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Healthcare Senior Account Manager: Competitive

Healthcare Lead Copywriter: Competitive

PMHub

Add my company

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

The pandemic preparedness paradox: Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Sourcing R&D innovation: why pharma companies need to evolve their business models: Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?: 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...